Apriem Advisors Abb Vie Inc. Transaction History

Apriem Advisors

$849 Million
Q3 2024

A detailed history of Apriem Advisors transactions in Abb Vie Inc. stock. As of the latest transaction made, Apriem Advisors holds 12,434 shares of ABBV stock, worth $2.05 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares

12,434

Previous 12,572 1.1%

Holding current value

$2.05 Million

Previous $2.16 Million 13.87%

% of portfolio

0.29%

Previous 0.26%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$163.84 - $199.33 $22,609 - $27,507	-138 Reduced 1.1%	12,434 $2.46 Million
Q2 2024 Aug 14, 2024	SELL	$154.79 - $180.76 $16,562 - $19,341	-107 Reduced 0.84%	12,572 $2.16 Million
Q1 2024 May 15, 2024	SELL	$159.82 - $182.1 $2.05 Million - $2.33 Million	-12,797 Reduced 50.23%	12,679 $2.31 Million
Q4 2023 Feb 14, 2024	SELL	$137.6 - $154.97 $142,553 - $160,548	-1,036 Reduced 3.91%	25,476 $3.95 Million
Q3 2023 Nov 13, 2023	SELL	$133.59 - $154.65 $645,106 - $746,804	-4,829 Reduced 15.41%	26,512 $3.95 Million
Q2 2023 Aug 08, 2023	BUY	$132.51 - $164.9 $895,370 - $1.11 Million	6,757 Added 27.49%	31,341 $4.22 Million
Q1 2023 May 12, 2023	BUY	$144.61 - $166.54 $1.77 Million - $2.03 Million	12,212 Added 98.71%	24,584 $3.92 Million
Q4 2022 Feb 13, 2023	SELL	$138.31 - $165.87 $51,589 - $61,869	-373 Reduced 2.93%	12,372 $2 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $111,125 - $127,454	-828 Reduced 6.1%	12,745 $1.71 Million
Q2 2022 Aug 08, 2022	SELL	$137.62 - $174.96 $77,480 - $98,502	-563 Reduced 3.98%	13,573 $2.08 Million
Q1 2022 May 10, 2022	SELL	$131.98 - $163.75 $118,122 - $146,556	-895 Reduced 5.95%	14,136 $2.29 Million
Q4 2021 Feb 09, 2022	BUY	$107.43 - $135.93 $3,974 - $5,029	37 Added 0.25%	15,031 $2.04 Million
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $3,404 - $3,864	32 Added 0.21%	14,994 $1.62 Million
Q2 2021 Aug 10, 2021	BUY	$105.21 - $117.21 $12,835 - $14,299	122 Added 0.82%	14,962 $1.69 Million
Q1 2021 May 10, 2021	SELL	$102.3 - $112.62 $5,115 - $5,631	-50 Reduced 0.34%	14,840 $1.61 Million
Q4 2020 Feb 04, 2021	BUY	$80.49 - $108.67 $47,006 - $63,463	584 Added 4.08%	14,890 $1.6 Million
Q3 2020 Nov 10, 2020	BUY	$85.91 - $100.83 $31,271 - $36,702	364 Added 2.61%	14,306 $1.25 Million
Q2 2020 Aug 07, 2020	BUY	$73.37 - $98.18 $258,555 - $345,986	3,524 Added 33.83%	13,942 $1.37 Million
Q1 2020 May 07, 2020	BUY	$64.5 - $97.79 $9,159 - $13,886	142 Added 1.38%	10,418 $794,000
Q4 2019 Feb 10, 2020	SELL	$72.13 - $90.25 $25,245 - $31,587	-350 Reduced 3.29%	10,276 $910,000
Q3 2019 Nov 12, 2019	SELL	$62.98 - $75.72 $5.26 Million - $6.33 Million	-83,540 Reduced 88.72%	10,626 $805,000
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $455,038 - $581,645	6,926 Added 7.94%	94,166 $6.85 Million
Q1 2019 May 15, 2019	BUY	$77.14 - $90.79 $734,064 - $863,957	9,516 Added 12.24%	87,240 $7.03 Million
Q4 2018 Feb 19, 2019	BUY	$77.85 - $96.01 $533,350 - $657,764	6,851 Added 9.67%	77,724 $7.17 Million
Q3 2018 Nov 14, 2018	BUY	$88.91 - $98.84 $16,448 - $18,285	185 Added 0.26%	70,873 $6.7 Million
Q2 2018 Aug 14, 2018	BUY	$89.78 - $106.23 $309,741 - $366,493	3,450 Added 5.13%	70,688 $6.55 Million
Q1 2018 May 11, 2018	SELL	$92.01 - $123.21 $399,875 - $535,470	-4,346 Reduced 6.07%	67,238 $6.36 Million
Q4 2017 Feb 14, 2018	SELL	$89.56 - $98.21 $270,471 - $296,594	-3,020 Reduced 4.05%	71,584 $6.92 Million
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $5.21 Million - $6.66 Million	74,604	74,604 $6.63 Million

Others Institutions Holding ABBV

# of Institutions

3,841

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $292B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Apriem Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Apriem Advisors with notifications on news.

Account